APP and Alzheimer disease: Subsequent findings in transgenic mice and human AD brain samples showed increased mRNA levels of collagen type VI proteins in a dose-dependent proportion to the expression of APP and Aβ, also suggesting potential protective roles of this collagen against Aβ neurotoxicity (111).